Cargando…

Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency

Introduction: Classical congenital adrenal hyperplasia is associated with an increased risk of obesity and cardiometabolic disease. The aim of the study was to determine if this is also true for non-classical congenital adrenal hyperplasia (NCCAH). Methods: A retrospective, cross-sectional, single-c...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries, Liat, Lebenthal, Yael, Phillip, Moshe, Shalitin, Shlomit, Tenenbaum, Ariel, Bello, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798148/
https://www.ncbi.nlm.nih.gov/pubmed/31681171
http://dx.doi.org/10.3389/fendo.2019.00698
_version_ 1783459980136939520
author de Vries, Liat
Lebenthal, Yael
Phillip, Moshe
Shalitin, Shlomit
Tenenbaum, Ariel
Bello, Rachel
author_facet de Vries, Liat
Lebenthal, Yael
Phillip, Moshe
Shalitin, Shlomit
Tenenbaum, Ariel
Bello, Rachel
author_sort de Vries, Liat
collection PubMed
description Introduction: Classical congenital adrenal hyperplasia is associated with an increased risk of obesity and cardiometabolic disease. The aim of the study was to determine if this is also true for non-classical congenital adrenal hyperplasia (NCCAH). Methods: A retrospective, cross-sectional, single-center study design was used. Data were collected on 114 patients (92 female) with NCCAH diagnosed during childhood/adolescence at a tertiary medical center. Patients were classified by treatment status at the last clinic visit. Outcome measures were assessed at diagnosis and the last clinic visit: weight status, body composition, blood pressure, lipid profile, and glucose metabolism. The prevalence of overweight/obesity was compared to the parental prevalence, and for patients aged 11–20 years, to the Israeli National Survey. Results: Mean age was 7.9 ± 4.2 years at diagnosis and 17.1 ± 6.9 years at the last follow-up. At the last clinic visit, 76 patients were under treatment with glucocorticoids, 27 were off-treatment (previously treated), and 11 had never been treated. The rate of obesity (11.4%) was similar to the parental rates, and the rate of overweight was significantly lower. In patients 11–20 years old, rates of obesity or obesity + overweight were similar to the general Israeli population (11.4 vs. 15.1%, P = 0.24 and 34.2 vs. 41.6% P = 0.18, respectively). No significant difference was found between glucocorticoid-treated and off-treatment patients in any of the metabolic or anthropometric parameters evaluated, except for a lower mean fat mass (% of body weight) in off-treatment patients (23.0 ± 7.7% vs. 27.8 ± 6.8%, P = 0.06). Systolic hypertension was found in 12.2% of NCCAH patients either treated or untreated. Conclusion: NCCAH diagnosed in childhood, whether treated or untreated, does not pose an increased risk of overweight, obesity, or metabolic derangements in adolescence and early adulthood.
format Online
Article
Text
id pubmed-6798148
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67981482019-11-01 Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency de Vries, Liat Lebenthal, Yael Phillip, Moshe Shalitin, Shlomit Tenenbaum, Ariel Bello, Rachel Front Endocrinol (Lausanne) Endocrinology Introduction: Classical congenital adrenal hyperplasia is associated with an increased risk of obesity and cardiometabolic disease. The aim of the study was to determine if this is also true for non-classical congenital adrenal hyperplasia (NCCAH). Methods: A retrospective, cross-sectional, single-center study design was used. Data were collected on 114 patients (92 female) with NCCAH diagnosed during childhood/adolescence at a tertiary medical center. Patients were classified by treatment status at the last clinic visit. Outcome measures were assessed at diagnosis and the last clinic visit: weight status, body composition, blood pressure, lipid profile, and glucose metabolism. The prevalence of overweight/obesity was compared to the parental prevalence, and for patients aged 11–20 years, to the Israeli National Survey. Results: Mean age was 7.9 ± 4.2 years at diagnosis and 17.1 ± 6.9 years at the last follow-up. At the last clinic visit, 76 patients were under treatment with glucocorticoids, 27 were off-treatment (previously treated), and 11 had never been treated. The rate of obesity (11.4%) was similar to the parental rates, and the rate of overweight was significantly lower. In patients 11–20 years old, rates of obesity or obesity + overweight were similar to the general Israeli population (11.4 vs. 15.1%, P = 0.24 and 34.2 vs. 41.6% P = 0.18, respectively). No significant difference was found between glucocorticoid-treated and off-treatment patients in any of the metabolic or anthropometric parameters evaluated, except for a lower mean fat mass (% of body weight) in off-treatment patients (23.0 ± 7.7% vs. 27.8 ± 6.8%, P = 0.06). Systolic hypertension was found in 12.2% of NCCAH patients either treated or untreated. Conclusion: NCCAH diagnosed in childhood, whether treated or untreated, does not pose an increased risk of overweight, obesity, or metabolic derangements in adolescence and early adulthood. Frontiers Media S.A. 2019-10-11 /pmc/articles/PMC6798148/ /pubmed/31681171 http://dx.doi.org/10.3389/fendo.2019.00698 Text en Copyright © 2019 de Vries, Lebenthal, Phillip, Shalitin, Tenenbaum and Bello. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
de Vries, Liat
Lebenthal, Yael
Phillip, Moshe
Shalitin, Shlomit
Tenenbaum, Ariel
Bello, Rachel
Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
title Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
title_full Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
title_fullStr Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
title_full_unstemmed Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
title_short Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
title_sort obesity and cardiometabolic risk factors in children and young adults with non-classical 21-hydroxylase deficiency
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798148/
https://www.ncbi.nlm.nih.gov/pubmed/31681171
http://dx.doi.org/10.3389/fendo.2019.00698
work_keys_str_mv AT devriesliat obesityandcardiometabolicriskfactorsinchildrenandyoungadultswithnonclassical21hydroxylasedeficiency
AT lebenthalyael obesityandcardiometabolicriskfactorsinchildrenandyoungadultswithnonclassical21hydroxylasedeficiency
AT phillipmoshe obesityandcardiometabolicriskfactorsinchildrenandyoungadultswithnonclassical21hydroxylasedeficiency
AT shalitinshlomit obesityandcardiometabolicriskfactorsinchildrenandyoungadultswithnonclassical21hydroxylasedeficiency
AT tenenbaumariel obesityandcardiometabolicriskfactorsinchildrenandyoungadultswithnonclassical21hydroxylasedeficiency
AT bellorachel obesityandcardiometabolicriskfactorsinchildrenandyoungadultswithnonclassical21hydroxylasedeficiency